Wednesday 31 July 2013

Field-Programmable Gate Array (FPGA) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Field programmable gate arrays (FPGA) are semiconductor devices or integrated circuits which can be programmed or reprogrammed even after the device has been installed. Compared to ASICs (application-specific integrated circuit), FPGAs offer several design advantages such as ability to re-program in the field for debugging, rapid prototyping, lower NRE(non recurring engineering) costs and long product life cycle to ease obsolescence risk. FPGAs also useful in verification and testing hardware without going through the long fabrication process. Designers can make required changes and can run number of iterations on FPGA circuit in hours.


Rising demand for customizable integrated circuits is one of the key factors contributing to the growth of FPGA market. The global FPGA market has also been witnessing growth for power-efficient and high-performance ICs. In order to reduce the time to promote original equipment manufacturers (OEM) across the globe are rapidly opting for Field Programmable Gate Arrays instead of application specific integrated circuits.

Increasing necessity of FPGA in imaging equipment of medical imaging for high performance computing abilities is further expected to drive field programmable gate arrays market. Owing to the increased automobile electronic gadgets, Asia Pacific is expected to dominate the FPGA market in the near future trailed by U.S. and Europe. Issues faced by field programmable gate array start-ups could pose a challenge to the growth of FPGA market. However, implementing alternative techniques to tackle the growing design complexities in FPGA would help this market to sustain in the long term.

Some of the key the key participants in field programmable gate arrays market include Xilinx ,Altera, Lattice Semiconductor, Achronix, Altera, e2v (QP Semiconductor), MicroSemi (Actel), Tabula, SiliconBlue Technologies, Vantis, Aeroflex Inc, Anadigm, IncXeltek, QP Semiconductor Cypress, Pericom and Quicklogic Corp. among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Gastrointestinal Endoscopic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Devices used to inspect the internal lining of the gastrointestinal tract are termed as gastrointestinal endoscopic devices. Gastrointestinal (GI) tract includes small intestine, large intestine, duodenum, colon, stomach, cecum and rectum. Any infection or abnormalities in function of this GI tract is detected for using gastrointestinal endoscopic devices. These devices are helpful in detecting the cause of abdominal bleeding, vomiting, persistent pain, inflammation and tumor affecting the esophagus, duodenum and stomach. In addition they also help in treating these GI diseases. Various GI diseases include ulcer, gastroesophageal reflux disease, hemorrhoids, colon cancer, diverticulitis, bowel syndrome and Crohn’s disease. 


Gastrointestinal endoscopic devices include thin flexible tube, light attached to thin flexible tube and a visualizer. Other components of this device are viewing sheath, power source, rheostat, lasers, insufflators, battery box, bulbs, fiberoptic lighting, hand instruments, electrosurgical and radiofrequency instruments. The process of detecting GI tract abnormalities through GI endoscopic devices is termed as gastrointestinal endoscopy. This process starts with anesthetizing the patient and then putting thin wire in the GI tract through mouth. The internal structure image is displayed on the visualizer. This image helps the physician to detect and treat the GI infections.

Gastrointestinal endoscopic devices are further segmented as endoscopic retrograde cholangiopancreatography devices (ERCP), hemostatis devices, capsule endoscopy, biopsy devices and GI videoscopes. GI videoscopes include video gastroscopes, video duodenoscopes, video colonoscopies, video ultrasound endoscopes, video enteroscope and video sigmoidoscope. Other GI endoscopic devices include stents, enteral feeding devices, esophageal dilation balloons, polypectomy snares, and anti-reflux devices. 

Changing lifestyle has changed the diet pattern. The new diet has reduced the intake of various healthy foods which increases the incidence of digestive tract problems. In addition, increase in GI diseases has also triggered the growth of this market. Recently in year 2011, 1 million of the total worldwide population has been detected with colon and rectum cancer. Weight management treatment has also contributed in its growth since this therapy includes gastric banding and bypass surgery. Global increase in disposable income has also boosted the growth of this market. Despite all the advantages, the growth of this market would be hampered due to lack of sufficient reimbursement policies and reduced government funding in various nations such as Europe and U.S. respectively. In addition, high costs and delayed approval process would also hinder the growth of this market.

Some of the major market players in this industry are Covidien Ltd., Boston Scientific Corporation, Conmed Corporation, Johnson & Johnson Ltd., Fujinon Ltd., Stryker Corporation and other significant players.


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments. 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Therapeutic Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

Therapeutic vaccines function by triggering a body immune response against a disease. The global therapeutic vaccines market was valued at USD 292 million in 2011. The introduction of therapeutic vaccines has opened up new avenues in the field of chronic disease treatment and prophylactic immunization. Provenge was the first U.S. FDA approved immunotherapy drug to treat prostate cancer in men in 2010, which has encouraged rigorous research and development initiatives by pharmaceutical companies to develop novel vaccines for untapped disease segments. As a result of these initiatives, many more therapeutic vaccines are currently in the pipeline such as breast cancer vaccine, lung cancer vaccine; Alzheimer’s vaccine, malaria vaccine, and diabetes vaccine are expected to be introduced in the market during the period from 2012 to 2018.


The market is currently facing growth hindrances as R&D approaches, and regulatory and reimbursement policies are inconspicuous owing to the nascent nature of the market. However, regulatory bodies are working enthusiastically to lay out policies and growth strategies, due to the fact that it holds the potential to solve or curb chronic diseases, with no currently available treatments, such as HIV AIDS.

Four components hold imperative importance in designing a therapeutic vaccine:
  • Antigens: These are substances that evoke an immune response from the body and are responsible for the production of antibodies.
  • Adjuvants: These are immunological agents that help in modifying the effects of a drug or vaccine. Companies are now engaged in designing new adjuvants that will help in enhancing the immunogenicity of an antigen.
  • Cost effective production systems for vaccines.
  • Designing innovative drug delivery devices to enhance vaccine efficacy.
The North American therapeutic vaccine market is expected to generate the maximum revenue in the global market during the forecasted period due to the presence of efficient R&D facilities and sophisticated medical infrastructures. The market is segmented into three major application segments namely oncology, infectious diseases and other chronic disorders. The therapeutic vaccine market with oncology applications market held the majority of the market share in 2011, as most of the research and development exercises are expected to be directed towards this segment during 2012 to 2018.

Merck and GSK have strong therapeutic vaccine product pipelines and are expected to perform better during 2012 to 2018 than their competitors who have fewer products in the pipeline. Some of the other key players of the market include Sanofi-Pasteur, Cytos Biotechnology AG, and Intellect Neurosciences.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
All new upcoming reports: http://www.transparencymarketresearch.com/latest.php?type=U
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Hepatitis Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast (2012 - 2018)

Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected with any one form of hepatitis and around 500,000 people die every year according to World Health Organization.


Hepatitis A is a simpler form of which does not lead to chronic infections. Patients suffering from hepatitis A recover within two months as this form is less complicated and can be prevented with vaccination. Although hepatitis B can be prevented by vaccination, once infected, a person can develop lifelong chronic infection resulting into severe liver damage. More than 2 billion people of the global population are infected with hepatitis B. Hepatitis C is most dangerous of among all the types of hepatitis as 80% of the hepatitis C infected patients get chronically infected. Around 150 million people are infected with hepatitis C worldwide and 350,000 people die every year. No vaccine is yet available for prevention of hepatitis C.

Hepatitis A, B, C, D and E can be diagnosed by combinations of various specific tests containing enzymes, antibodies and antigens. These are: enzyme immunoassay (EIA), recombinant immunoblot assay (RIBA), transcription-mediated amplification (TMA) and polymerase chain reaction (PCR). The EIA technology is used for antibody as well as antigen detection whereas the other technologies are used to test DNA and RNA to check the presence of hepatitis viruses.

Hepatitis A and E are mainly caused by consumption of contaminated food or water. Hepatitis B, C and D occur as a result of contact with infected body fluids. Common modes of transmission and infection for these viruses include receipt of infected blood or blood products, invasive medical procedures using contaminated equipments. Hepatitis B can be transmitted from mother to baby at the time of birth and by sexual contact. Prevalence of hepatitis A, hepatitis B and hepatitis C in North American countries is 33%, 5% and 1.5% respectively. Thus, North America has registered the highest cases of hepatitis infections followed by Asia-Pacific and then Europe.

Some of the key players involved in the development of diagnostics for hepatitis are Siemens AG, MedMira Inc., Inovio Pharmaceuticals, Inc. and Abbott Laboratories.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Tuesday 30 July 2013

Lymphoma Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

Lymphoma is a kind of blood cancer which occurs when B or T lymphocytes and leukocytes grow abnormally. In addition, it also occurs if these cells survive longer than their normal life cycle. Lymphoma generally occurs in lymph nodes, bone marrow, spleen, blood and other organs which form a part of the lymphatic system. The common symptoms of lymphoma are swelling of lymph nodes, fever, weight loss, night sweets, anorexia, itching, dyspnoea and fatigue. The common tests applied for the diagnosis of lymphoma are immunophenotyping, FISH (Fluorescence in Situ Hybridization) testing and flow cytometry. The most common method to threat lymphoma is chemotherapy.


Since chemotherapy destroys the cancer cell by obstructing its division process, it acts as one of the key method for lymphoma treatment. These medicines travels throughout the body while medication. Various drugs are used for the treatment of lymphoma such as Adcertis (brentuximab), Arranon (nelarabine), Adriamycin (doxorubicin), Decadron (dexamethasone), Baycadron (dexamethasone), Deltasone (prednisone), Dexamethasone Intensol (dexamethasone), Dexpak Taperpak (dexamethasone) and Folotyn (pralatrexate). Other drugs used include Prednicot (prednisone), Roferon-A (interferon alfa-2a), Solurex (dexamethasone), Leukeran (chlorambucil), Zema Pak (dexamethasone), Velcade (bortezomib), Sterapred DS (prednisone), Thioplex (thiotepa), Velban (vinblastine) and Trexall (methotrexate).

Rise in the incidence of lymphoma throughout the globe would boost the growth of lymphoma treatment drugs market. According to Leukemia and Lymphoma Society, in 2012, around 700,000 people were suffering from lymphoma in Canada alone. The government of various nations such as U.S. and Europe has amplified their funding for R&D on lymphoma treating drugs which would further augment the growth of this market. Moreover, they have started many programs for patient awareness about lymphoma and its treatments. Despite all these advantages, various side effects of chemotherapy would hamper the growth of this market. These side effects include hair loss, nausea, vomiting and fatigue. In addition, high cost of this treatment would also hamper the growth of this market. Moreover, few nations such as U.K are not providing reimbursement for every lymphoma treating drug which would hamper its growth in this region. Some of the major players in lymphoma treatment drugs market includes Abbott Laboratories, Eli Lilly, Bristol-Myers Squibb, Abiogen, Johnson & Johnson, Aeterna Zentaris among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

In Vitro Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 - 2019)

In vitro diagnostic test are the kind of medical tests which are performed to detect diseases, infections and pathological conditions. These tests are performed in test tubes or in controlled environment outside the patient’s body.  In vitro diagnostic tests are executed with the help of reagents, reagent products, control materials and apparatus such as laser and cell, to examine specimens like blood and tissue.


To detect wide array of diseases, a variety of in vitro diagnostic tests are performed such as immunoassay, molecular diagnostics, hematology, flow cytometry, coagulation and clinical chemistry. Immunoassay is a biochemical test, used to detect the presence of analyte in the specimen with the use of immunoglobulin or antibody. They are used to detect pregnancy, heart diseases, prostate cancer and others. Molecular diagnostic test detects specific sequences in DNA or RNA including single nucleotide polymorphism (SNP), deletion, insertion and rearrangement which may or may not be associated with the diseases. They are helpful in detecting infectious and genetic diseases, pharmacogenomic and cancer.

Hematology diagnostic tests use blood as the sample to diagnose illness or disorders. They are helpful in detection of cancer, blood diseases and blood protein. Flow cytometry diagnostic tests are performed to count and sort cell, detect biomarker and protein in the sample which is passed through an electronic detection apparatus. They are majorly used to detect blood cancer. Coagulation diagnostic tests are involved in diagnosis of hemostasis system through coagulometer. Clinical chemistry tests are performed to detect the significant amount of substances in urine, blood, body fluid and tissues.

In vitro diagnostic test provides better and accurate detection of different diseases and hence helps in providing specific treatment for the same. Rise in incidence of chronic and infectious diseases amongst aging population coupled with increasing awareness in developed nations such as U.S. and Europe have augmented the growth of this market. Lack of awareness and disposable income in developing nations has negatively impacted the growth of this market.

Some of the market players in this industry segment are Roche Diagnostics, Abbott Laboratories, Siemens Medical, Beckman Coulter Inc. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics.
  • It provides a forward looking perspective on different factors driving or restraining market growth.
  • It provides a technological growth map over time to understand the industry growth rate.
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow. 
  • It helps in understanding the key product segments and their future.
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments. 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Automotive Aluminum Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2012 - 2018)

The automotive industry is committed creating a generation of vehicles that offers superior fuel efficiency without compromising safety, performance, or comfort. Aluminum offers automakers the opportunity to design and manufacture safe, high-performance, energy-efficient, corrosion resistance and environmentally friendly vehicles that are much lighter in weight. In addition to taking advantage of the lighter mass of aluminum compared to steel for the body of the vehicle, further weight reduction is possible through secondary weight savings in the engine, transmission, brakes, wheels, tires, fuel tank, and other systems.


Substituting one pound of aluminum for steel parts, the auto designers can remove 2.0 to 2.5 pounds of cast iron, making the use of aluminum very attractive. The majority of this aluminum is used in automotive and light truck applications. Aluminum used in cars and trucks are segmented depending on their used as aluminum casting, as aluminum extrusion, as aluminum Flat Rolled Products (FRP) aluminum sheets. Cast products contribute more than half of the aluminum used in cars. Cast aluminum transmission housing and pistons have been virtually universal in cars and trucks throughout the world. Aluminum sheet is currently used in two classes of automotive applications including auto body frame and closure panels. Heat exchanger fins and plates and aluminum sheets for chassis are some of the applications in it. Extruded aluminum is the material of choice for countless applications such as sun roof channels and roof rails. Various alloys can be readily formed into complex shapes. Two wheeler industry mainly used aluminum for manufacturing alloy wheels. 

One of the major factors driving this market is continuous growth in automotive production and sales. Government regulations on environment are also enhancing the growth of this market as 90% of aluminum can be recycled. Increasing fuel price is also boosting the usage of aluminum as reduction in weight of vehicles saves 5 to 7% of fuel. The availability of other lightweight material (reinforced plastic and magnesium) could pose a challenge to the growth of this market. Asia Pacific is the fastest growing market for automotive aluminum industry due to the rapid industrialization in China. Europe dominates the market with largest car manufacturers followed by APAC, North America, Latin America and rest of the world.

Some of the major companies in this market are Alcan, Alcoa, Aluminum Precision Products, Grupo Metalur, Kaiser Aluminum, Lorin, Novelis, Rio Tinto, Sapa Group, Superior Aluminum Alloys Inc. and others.


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.